$11.310
+0.031 (+0.27%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ARTV por análisis de gráficos similares
Alphio's ARTV stock price prediction model matches the current Artiva Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.35 (+0.36%). The 1-week path is $11.08 (-2.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Artiva Biotherapeutics Inc?
Artiva Biotherapeutics Inc is a good buy right now due to its recent clinical trial results showing a 71% ACR50 response rate for its AlloNK therapy, which indicates significant potential in treating rheumatoid arthritis. Additionally, the stock has a current price of $11.09, which is well below the analyst price targets of $40 and $41, suggesting substantial upside potential. However, investors should be cautious of the company's ongoing net losses, which reached $23.5 million in Q1 2026, as this poses a risk to future profitability.
ARTV cerró en $11.31 el Wednesday, tras subir +0.27%
Artiva Biotherapeutics Inc (ARTV) last closed at $11.31, gaining +0.27%. These facts feed the 1-day and 1-week ARTV price prediction above.
Factores de la previsión
Los factores de la previsión de Artiva Biotherapeutics Inc (ARTV) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ARTV, ordenadas por similitud.
Análisis de estacionalidad de ARTV
Historically the probability of a positive September return for ARTV is 25.00%. June offers the highest probability of a positive month at 51.22%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ARTV
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $2.79 | $2.89 | $3.09 | -74.48% |
| Oct 2026 | $2.54 | $2.62 | $3.16 | -76.84% |
| Nov 2026 | $2.11 | $2.54 | $2.64 | -77.54% |
| Dec 2026 | $2.58 | $2.89 | $3.02 | -74.48% |
En 2026, se proyecta que Artiva Biotherapeutics Inc (ARTV) oscile entre $2.11 y $3.16.
Previsión mensual de Artiva Biotherapeutics Inc para 2026
En Sep de 2026, se proyecta que Artiva Biotherapeutics Inc promedie $2.89, con un mínimo de $2.79 y un máximo de $3.09.
En Oct de 2026, se proyecta que Artiva Biotherapeutics Inc promedie $2.62, con un mínimo de $2.54 y un máximo de $3.16.
En Nov de 2026, se proyecta que Artiva Biotherapeutics Inc promedie $2.54, con un mínimo de $2.11 y un máximo de $2.64.
En Dec de 2026, se proyecta que Artiva Biotherapeutics Inc promedie $2.89, con un mínimo de $2.58 y un máximo de $3.02.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.